LIP
Lighthouse Investment Partners Portfolio holdings
AUM
$2.3B
1-Year Return
18.81%
This Quarter Return
+8.15%
1 Year Return
+18.81%
3 Year Return
+54.09%
5 Year Return
–
10 Year Return
–
AUM
$1.7B
AUM Growth
+$329M
(+24%)
Cap. Flow
+$258M
Cap. Flow
% of AUM
15.14%
Top 10 Holdings %
Top 10 Hldgs %
17.24%
Holding
464
New
180
Increased
80
Reduced
72
Closed
105
Top Buys
| 1 |
Keurig Dr Pepper
KDP
|
$24.1M |
| 2 |
TD Synnex
SNX
|
$22.6M |
| 3 |
Progressive
PGR
|
$15.3M |
| 4 |
Church & Dwight Co
CHD
|
$15.1M |
| 5 |
Kraft Heinz
KHC
|
$14.6M |
Top Sells
| 1 |
Philip Morris
PM
|
$38.5M |
| 2 |
Mondelez International
MDLZ
|
$16.7M |
| 3 |
Target
TGT
|
$14.8M |
| 4 |
Rexford Industrial Realty
REXR
|
$14.6M |
| 5 |
Truist Financial
TFC
|
$13.5M |
Sector Composition
| 1 | Real Estate | 21.57% |
| 2 | Consumer Staples | 18.35% |
| 3 | Financials | 14.53% |
| 4 | Healthcare | 13.03% |
| 5 | Consumer Discretionary | 9.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Liquidia Corp
LQDA
$2.41B
| $511K | 0.02% |
+34,659
| New | +$511K |
|
302
Colliers International
CIGI
$8.47B
| $505K | 0.02% |
+4,132
| New | +$505K |
|
303
MacroGenics
MGNX
$111M
| $504K | 0.02% |
+34,211
| New | +$504K |
|
304
Keros Therapeutics
KROS
$628M
| $503K | 0.02% |
+7,593
| New | +$503K |
|
305
Viridian Therapeutics
VRDN
$1.62B
| $497K | 0.02% |
+28,406
| New | +$497K |
|
306
PennyMac Financial
PFSI
$6.26B
| $497K | 0.02% |
+5,459
| New | +$497K |
|
307
Ciena
CIEN
$16.8B
| $495K | 0.02% |
+10,000
| New | +$495K |
|
308
Exxon Mobil
XOM
$468B
| $478K | 0.02% |
4,116
-50,008
| -92% | -$5.81M |
|
309
Trip.com Group
TCOM
$47.7B
| $474K | 0.02% |
+10,800
| New | +$474K |
|
310
Goosehead Insurance
GSHD
$2.14B
| $474K | 0.02% |
+7,111
| New | +$474K |
|
311
Bilibili
BILI
$9.31B
| $474K | 0.02% |
+42,278
| New | +$474K |
|
312
SPDR S&P Regional Banking ETF
KRE
$3.99B
| $470K | 0.02% |
9,355
-108,387
| -92% | -$5.45M |
|
313
NVIDIA
NVDA
$4.1T
| $452K | 0.02% |
+5,000
| New | +$452K |
|
314
FibroGen
FGEN
$45.1M
| $428K | 0.02% |
7,284
+1,133
| +18% | +$66.6K |
|
315
Alto Neuroscience
ANRO
$105M
| $427K | 0.02% |
+27,823
| New | +$427K |
|
316
Brookfield Renewable
BEPC
$6B
| $415K | 0.02% |
16,900
-3,070
| -15% | -$75.3K |
|
317
Sutro Biopharma
STRO
$83.3M
| $376K | 0.02% |
+66,585
| New | +$376K |
|
318
A.O. Smith
AOS
$10.4B
| $358K | 0.02% |
+4,000
| New | +$358K |
|
|
ITOS
319
DELISTED
iTeos Therapeutics
ITOS
| $334K | 0.02% |
+24,473
| New | +$334K |
|
320
iShares MSCI Thailand ETF
THD
$237M
| $328K | 0.02% |
+5,608
| New | +$328K |
|
321
Atkore
ATKR
$1.97B
| $315K | 0.01% |
+1,654
| New | +$315K |
|
322
Foot Locker
FL
$2.29B
| $300K | 0.01% |
+10,522
| New | +$300K |
|
323
Bausch + Lomb
BLCO
$5.49B
| $277K | 0.01% |
+16,000
| New | +$277K |
|
324
Lyell Immunopharma
LYEL
$250M
| $274K | 0.01% |
+6,150
| New | +$274K |
|
325
Zurn Elkay Water Solutions
ZWS
$7.82B
| $273K | 0.01% |
+8,159
| New | +$273K |
|